metronidazole and tirzepatide Delivers Again | Climate Change Driving CVD How Does Tirzepatide Work? |
Description
In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)
Results Seven trials (6609 participants) were included
Uncover the secrets to navigating stalls, fluctuations, and success on GLP-1 medications
Conclusions/interpretation Tirzepatide improves therapeutic target attainment compared with semaglutide in type 2 diabetes
